Clinical research is undergoing a significant digital shift as sponsors, CROs, pharmaceutical companies, medical device firms, and healthcare organizations increasingly replace paper-based processes with electronic data capture. This transformation is creating new opportunities across the Electronic Clinical Outcome Assessment Solutions Market, which was valued at USD 1.36 billion in 2022 and...
The global anti-hiv drugs market is witnessing steady growth as healthcare systems continue to expand access to antiretroviral therapy, improve HIV diagnosis and treatment programs, and strengthen long-term disease management. Anti-HIV drugs include multiple classes of antiretroviral medicines used in combination therapies to suppress HIV replication, maintain immune function, and reduce the...
The global chondroitin sulfate market was valued at USD 1.80 billion in 2025 and is projected to grow from USD 1.87 billion in 2026 to USD 2.54 billion by 2034 , recording a CAGR of 3.9% during 2026-2034 . North America dominated the market with a 38.7% share in 2025 , while Europe is expected to register the fastest CAGR of 4.58% .
Market Size (2025): USD 1.80 Billion
Market Size...
The weight management industry is moving through a major shift as pharmaceutical treatments become an increasingly visible part of obesity care. GLP-1-based medicines have moved from being primarily associated with metabolic disease management to becoming a major category within weight loss treatment, supported by rising obesity prevalence, clinical efficacy, greater awareness, and expanding...
For decades, the treatment of vascular disease was strongly associated with major surgical intervention. That picture is changing. As clinicians increasingly favor catheter-based approaches and device technologies become more precise, the treatment journey is moving toward interventions that can restore blood flow while limiting procedural burden. This broader change is creating sustained...
Healthcare organizations are increasingly turning to technology to make clinical decisions more accurate, consistent, and patient-focused. Against this backdrop, the clinical decision support systems market is projected to grow from USD 7.0 billion in 2026 to USD 15.3 billion by 2033, registering a CAGR of 11.8%.
The market was valued at USD 6.4 billion in...
The Middle East Healthcare Digital Twins Market is moving from experimental applications toward more connected, data-driven healthcare delivery. Valued at USD 29.56 million in 2025, the market is projected to reach USD 135.20 million by 2033, expanding at a CAGR of 20.58% from 2026 to 2033. Government-led digital health programs, smart hospital development, and demand...
Global AI Capsule Endoscopy Polyp Detection Video Processor Market is gaining rapid momentum as healthcare systems worldwide intensify efforts to improve colorectal cancer screening efficiency and diagnostic accuracy. Advanced deep‑learning algorithms embedded within video processors now enable real‑time polyp detection, dramatically reducing the time clinicians spend reviewing lengthy capsule...
Dopamine Agonists Market
The global Dopamine Agonists Market is witnessing steady growth as the prevalence of neurological disorders such as Parkinson's disease, restless legs syndrome (RLS), and hyperprolactinemia continues to increase worldwide. According to Straits Research, the global dopamine agonists market size was valued at USD 1.35 billion in 2025 and is...
The global Bioadhesives Market, valued at approximately USD 6.87 billion in 2025, is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 11.1% , reaching an estimated USD 15.95 billion by 2032. The market's expansion is fueled by rising environmental concerns, stringent regulations on synthetic chemicals, increasing demand for sustainable...
The global Thiothixene API Market, valued at approximately USD 15.2 million in 2025, is projected to grow at a steady Compound Annual Growth Rate (CAGR) of 4.1% , reaching an estimated USD 20.8 million by 2032. The market's expansion is fueled by the persistent global burden of schizophrenia, consistent demand for established, cost-effective treatments, and the presence...
The global Diisopropyl Ether (DIPE) Low-Boiling Extraction Solvent Pharma Market, valued at approximately USD 330.5 million in 2026, is projected to grow at a steady Compound Annual Growth Rate (CAGR) of 5.7% , reaching an estimated USD 540.2 million by 2034. The market's expansion is fueled by regulatory preference for low-boiling solvents, enhanced extraction...